AEON Biopharma Statistics

Total Valuation

AEON Biopharma has a market cap or net worth of $6.21 million. The enterprise value is $19.05 million.

Market Cap	6.21M
Enterprise Value	19.05M

Important Dates

The last earnings date was Monday, March 24, 2025, after market close.

Earnings Date	Mar 24, 2025
Ex-Dividend Date	n/a

Share Statistics

AEON Biopharma has 10.53 million shares outstanding. The number of shares has decreased by -99.25% in one year.

Current Share Class	10.53M
Shares Outstanding	10.53M
Shares Change (YoY)	-99.25%
Shares Change (QoQ)	+1.19%
Owned by Insiders (%)	0.32%
Owned by Institutions (%)	12.34%
Float	10.36M

Valuation Ratios

The trailing PE ratio is 0.01.

PE Ratio	0.01
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	-0.21
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	0.45
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.11

Current Ratio	0.11
Quick Ratio	0.00
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-348.25%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	252.78%
Revenue Per Employee	n/a
Profits Per Employee	$4.20M
Employee Count	10
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -99.93% in the last 52 weeks. The beta is 0.35, so AEON Biopharma's price volatility has been lower than the market average.

Beta (5Y)	0.35
52-Week Price Change	-99.93%
50-Day Moving Average	4.73
200-Day Moving Average	53.68
Relative Strength Index (RSI)	24.71
Average Volume (20 Days)	7,661,037

Short Selling Information

The latest short interest is 173,994, so 1.65% of the outstanding shares have been sold short.

Short Interest	173,994
Short Previous Month	37,021
Short % of Shares Out	1.65%
Short % of Float	1.68%
Short Ratio (days to cover)	0.02

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-27.82M
Pretax Income	n/a
Net Income	42.01M
EBITDA	-27.73M
EBIT	-27.82M
Earnings Per Share (EPS)	$72.93

Full Income Statement

Balance Sheet

The company has $13,000 in cash and $12.96 million in debt, giving a net cash position of -$12.94 million or -$1.23 per share.

Cash & Cash Equivalents	13,000
Total Debt	12.96M
Net Cash	-12.94M
Net Cash Per Share	-$1.23
Equity (Book Value)	-28.57M
Book Value Per Share	-51.43
Working Capital	-12.56M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-20.29M
Capital Expenditures	n/a
Free Cash Flow	-20.29M
FCF Per Share	-$1.93

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

AEON Biopharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	99.25%
Shareholder Yield	99.25%
Earnings Yield	688.18%
FCF Yield	-332.45%

Analyst Forecast

The average price target for AEON Biopharma is $360.00, which is 60,916.95% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$360.00
Price Target Difference	60,916.95%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on February 26, 2025. It was a reverse split with a ratio of 0.01388889:1.

Last Split Date	Feb 26, 2025
Split Type	Reverse
Split Ratio	0.01388889:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1